Gregory R. Hoffman
Novartis (Switzerland)(CH)Novartis Institutes for BioMedical Research
Publications by Year
Research Areas
CRISPR and Genetic Engineering, Protein Kinase Regulation and GTPase Signaling, Epigenetics and DNA Methylation, Pluripotent Stem Cells Research, Cellular transport and secretion
Most-Cited Works
- → p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells(2018)993 cited
- → Phosphoproteomic Analysis Identifies Grb10 as an mTORC1 Substrate That Negatively Regulates Insulin Signaling(2011)870 cited
- → Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening(2017)693 cited
- → Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5(2016)552 cited
- → DNA Repair Profiling Reveals Nonrandom Outcomes at Cas9-Mediated Breaks(2016)500 cited
- → Structure of the Rho Family GTP-Binding Protein Cdc42 in Complex with the Multifunctional Regulator RhoGDI(2000)491 cited